Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors

E-ISSN： 1873-4294|10|8|828-858

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.8, 2010-06, pp. : 828-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Endocannabinoid Derivatives as Templates for the Development of FAAH Inhibitors

Letters in Drug Design & Discovery, Vol. 2, Iss. 5, 2005-08 ,pp. : 372-376

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting enzyme inhibitors in drug discovery

By Copeland Robert A Harpel Mark R Tummino Peter J

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 967-978

Informa Healthcare

Access to resources Recommend Favorite

A Review of: “Evaluation of Enzyme Inhibitors in Drug Discovery”

By Woster Patrick

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 3, 2006-04 ,pp. : 399-400

Informa Healthcare

Access to resources Recommend Favorite

Endocannabinoid Transporter Inhibitors

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 2, 2002-06 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of New Inhibitors of Urease Enzyme: A Study Using STD-NMR Spectroscopy

Letters in Drug Design & Discovery, Vol. 12, Iss. 10, 2015-12 ,pp. : 819-9

Bentham Science Publishers

Access to resources Recommend Favorite